Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.
diterbitkan dalam: The Lancet Psychiatry
tanggal publikasi: 2015-12-23
subyek utama: Plasebo, treatment-resistant depression
Cites articles 34
Date
Judul
Artikel - wd:Q47924379